https://fk228inhibitor.com/eva....luation-of-diuretic-
Within the Chinese Clinical Trial Registry, the trial is identified by registration number ChiCTR1900022568. Patients with HER2-negative MBC, heavily pretreated with anthracycline and taxanes, experienced effective and well-tolerated treatment with PLD (Duomeisu) 40 mg/m2 every 4 weeks, suggesting a potentially viable therapeutic option for this patient group. Pertaining to the tr
Gefällt mir
Kommentar
Teilen
